Dyne Therapeutics, Inc. (DYN) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 550K | 521K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -550K | -521K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 125.28M | 115.61M | 113.89M | 115.79M | 122.37M | 97.11M | 105.66M | 71.96M | 69.16M | 67.69M | 62.27M | 66.74M | 45.46M | 40.15M | 42.28M | 52.76M | 35.78M | 51.96M | 42.77M | 30.16M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 24.39M | 20.7M | 16.67M | 16.55M | 15.93M | 15.3M | 12.86M | 9.7M | 24.62M | 8.84M | 7.02M | 7.61M | 7.93M | 6.95M | 7.61M | 6.09M | 7.55M | 9.66M | 6.26M | 6.29M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 100.89M | 95.43M | 97.22M | 99.24M | 106.45M | 81.81M | 92.8M | 62.26M | 44.54M | 58.84M | 55.25M | 59.13M | 37.54M | 33.19M | 34.67M | 46.66M | 28.24M | 42.3M | 36.51M | 23.87M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -521K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -125.28M | -116.13M | -113.89M | -115.79M | -122.37M | -97.11M | -105.66M | -71.96M | -69.16M | -67.69M | -62.27M | -66.74M | -45.46M | -40.15M | -42.28M | -52.76M | -35.78M | -51.96M | -42.77M | -30.16M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -2.37% | -19.59% | -7.79% | -60.91% | -76.95% | -43.46% | -69.67% | -7.83% | -52.11% | -68.61% | -47.29% | -26.5% | -27.05% | 22.74% | 1.14% | -74.89% | -42.37% | -81.68% | -216.32% | -247.72% |
| EBITDA | -124.73M | -115.61M | -113.37M | -115.29M | -121.87M | -96.66M | -105.22M | -71.56M | -68.77M | -67.29M | -61.84M | -66.31M | -45.05M | -39.74M | -41.88M | -52.3M | -35.36M | -51.62M | -42.51M | -29.92M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -2.34% | -19.61% | -7.74% | -61.1% | -77.21% | -43.65% | -70.14% | -7.93% | -52.65% | -69.31% | -47.66% | -26.79% | -27.42% | 23.01% | 1.47% | -74.81% | -42.02% | -81.87% | -218.52% | -251.25% |
| D&A (Non-Cash Add-back) | 550K | 521K | 523K | 503K | 502K | 450K | 438K | 399K | 386K | 399K | 431K | 431K | 412K | 401K | 397K | 460K | 425K | 341K | 260K | 249K |
| EBIT | -125.28M | -101.75M | -105.14M | -110.76M | -122.37M | -97.11M | -105.66M | -65.1M | -69.16M | -67.69M | -62.27M | -66.74M | -45.46M | -40.14M | -42.28M | -52.76M | -35.78M | -51.79M | -42.77M | -30.16M |
| Net Interest Income | 4.55M | 4.46M | 5.57M | 6.53M | 7.1M | 7.59M | 9.28M | 7.05M | 3M | 1.75M | 2.19M | 2.21M | 1.49M | 1.34M | 903K | 441K | 230K | 182K | 184K | 210K |
| Interest Income | 8.76M | 7.66M | 8.48M | 6.63M | 7.1M | 7.59M | 9.28M | 7.05M | 3M | 1.75M | 2.19M | 2.21M | 1.49M | 1.34M | 903K | 441K | 230K | 182K | 184K | 210K |
| Interest Expense | 4.2M | 3.19M | 2.9M | 94K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 4.42M | 4.17M | 5.85M | 4.93M | 7.01M | 7.57M | 8.53M | 6.86M | 3.51M | 1.05M | 2.06M | 1.83M | 1.28M | 1.32M | 894K | 451K | 200K | 174K | 184K | 210K |
| Pretax Income | -120.85M | -111.95M | -108.04M | -110.86M | -115.36M | -89.54M | -97.13M | -65.1M | -65.65M | -66.64M | -60.21M | -64.9M | -44.19M | -38.83M | -41.38M | -52.3M | -35.58M | -51.79M | -42.58M | -29.95M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -120.85M | -111.95M | -108.04M | -110.86M | -115.36M | -89.54M | -97.13M | -65.1M | -65.65M | -66.64M | -60.21M | -64.9M | -44.19M | -38.83M | -41.38M | -52.3M | -35.58M | -51.79M | -42.58M | -29.95M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -4.76% | -25.03% | -11.24% | -70.28% | -75.72% | -34.37% | -61.31% | -0.31% | -48.57% | -71.63% | -45.49% | -24.09% | -24.18% | 25.02% | 2.81% | -74.61% | -42.51% | -80.76% | -205.91% | -233.5% |
| Net Income (Continuing) | -120.85M | -111.95M | -108.04M | -110.86M | -115.36M | -89.54M | -97.13M | -65.1M | -65.65M | -66.64M | -60.21M | -64.9M | -44.19M | -38.83M | -41.38M | -52.3M | -35.58M | -51.79M | -42.58M | -29.95M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.73 | -0.76 | -0.76 | -0.97 | -1.05 | -0.88 | -0.96 | -0.70 | -0.81 | -1.09 | -0.99 | -1.08 | -0.75 | -0.71 | -0.78 | -1.01 | -0.69 | -1.00 | -0.83 | -0.58 |
| EPS Growth % | 30.48% | 13.64% | 20.83% | -38.57% | -29.63% | 19.27% | 3.03% | 35.19% | -8% | -53.52% | -26.92% | -6.93% | -8.7% | 29% | 6.02% | -74.14% | -38% | -56.25% | -167.74% | -163.64% |
| EPS (Basic) | -0.73 | -0.76 | -0.76 | -0.97 | -1.05 | -0.88 | -0.96 | -0.70 | -0.81 | -1.09 | -0.99 | -1.08 | -0.75 | -0.71 | -0.78 | -1.01 | -0.69 | -1.00 | -0.83 | -0.58 |
| Diluted Shares Outstanding | 165.04M | 128.44M | 141.81M | 113.87M | 109.91M | 101.98M | 100.88M | 92.51M | 81.04M | 61.39M | 61.11M | 59.84M | 56.33M | 52.47M | 51.8M | 51.68M | 51.6M | 51.54M | 51.32M | 51.22M |
| Basic Shares Outstanding | 165.04M | 128.44M | 141.81M | 113.87M | 109.91M | 101.98M | 100.88M | 92.51M | 81.04M | 61.39M | 61.11M | 59.84M | 56.33M | 52.47M | 51.8M | 51.68M | 51.6M | 51.54M | 51.32M | 51.22M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |